American Health Packaging recalls

American Health Packaging has 60 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 9 Sep 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls60since 2012

Last 12 months1reported

Class I23% of total

Ongoing1latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 1 0

Severity split

Class I 2 3%Class II 45 75%Class III 13 22%

Why american health packaging is recalled

Product types

Brands

By year

202612%
202247%
202147%
2020712%
20191322%
201835%
20151627%
2014610%
201347%
201223%

Ongoing american health packaging recalls

1 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Buprenorphine Sublingual Tablets (C-iii), 2 mg recalledBuprenorphine	American Health Packaging	Packaging Defects	Nationwide

All american health packaging recalls, newest first

60 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Buprenorphine Sublingual Tablets (C-iii), 2 mg recalledBuprenorphine	American Health Packaging	Packaging Defects	Nationwide
25 May 2022Drug	CLASS III	Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) recalled	American Health Packaging	Potency & Assay	Nationwide
4 May 2022Drug	CLASS III	Cyanocobalamin Injection, USP, 1000 mcg per mL recalled	American Health Packaging	Potency & Assay	AL
16 Mar 2022Drug	CLASS II	Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg recalledOxycodone Hydrochloride	American Health Packaging	Potency & Assay	Nationwide
2 Feb 2022Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol Succinate	American Health Packaging	Potency & Assay	Nationwide
27 Oct 2021Drug	CLASS II	GlipiZIDE Extended-Release Tablets, 2.5 mg recalled	American Health Packaging	Potency & Assay	Nationwide
6 Oct 2021Drug	CLASS II	Valproic Acid Oral Solution, USP, 500 mg/, 100 unit dose cups recalled	American Health Packaging	Manufacturing (CGMP) Deviations	Nationwide
29 Sep 2021Drug	CLASS III	Sirolimus Tablets 1 mg (5 blister cards x doses) recalledSirolimus	American Health Packaging	Potency & Assay	Nationwide
27 Jan 2021Drug	CLASS II	Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals) recalled	American Health Packaging	Potency & Assay	Nationwide
1 Jul 2020Drug	CLASS III	Nabumetone Tablets, USP, 500 mg per carton x 10 blister cards) recalled	American Health Packaging	Packaging Defects	Nationwide
17 Jun 2020Drug	CLASS II	Doxycycline Hyclate Tablets, USP, 100 mg per carton (3 recalledDoxycycline Hyclate	American Health Packaging	Potency & Assay	Nationwide
18 Mar 2020Drug	CLASS II	Ranitidine Tablets, USP, 150 mg x 10 blister card) recalled	American Health Packaging	Nitrosamine Impurity	Nationwide
26 Feb 2020Drug	CLASS II	Desmopressin Acetate Tablets, 0.2 mg ( unit dose blister cards) recalled	American Health Packaging	Processing Deviation	Nationwide
26 Feb 2020Drug	CLASS II	Desmopressin Acetate Tablets, 0.1 mg ( unit dose blister cards) recalled	American Health Packaging	Processing Deviation	Nationwide
19 Feb 2020Drug	CLASS II	Raloxifene Hydrochloride Tablets, USP, 60 mg ( blister cards) recalledRaloxifene Hydrochloride	American Health Packaging	Potency & Assay	Nationwide
8 Jan 2020Drug	CLASS II	Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL recalled	American Health Packaging	Nitrosamine Impurity	Nationwide
18 Sep 2019Drug	CLASS III	Lamivudine Tablets, USP, 150 mg Unit Dose Blisters recalled	American Health Packaging	Packaging Defects	Nationwide
21 Aug 2019Drug	CLASS II	Carbamazepine, Extended-Release Tablets, USP, 400 mg recalled	American Health Packaging	Potency & Assay	Nationwide
21 Aug 2019Drug	CLASS II	Aspirin and Extended-release Dipyridamole Capsules recalled	American Health Packaging	Potency & Assay	Nationwide
14 Aug 2019Drug	CLASS III	Lovastatin Tablets USP, 40 mg recalled by American Health Packaging	American Health Packaging	Potency & Assay	Nationwide
7 Aug 2019Drug	CLASS II	Doxycycline Hyclate Tablets, USP, 100 mg per carton recalledDoxycycline Hyclate	American Health Packaging	Potency & Assay	Nationwide
17 Jul 2019Drug	CLASS II	Anastrozole Tablets, USP, 1 mg, a) recalled by American Health PackagingAnastrozole	American Health Packaging	Processing Deviation	Nationwide
3 Jul 2019Drug	CLASS II	Pramipexole Dihydrochloride Tablets, 0.25 mg (10 recalled	American Health Packaging	Processing Deviation	Nationwide
3 Jul 2019Drug	CLASS II	Pramipexole Dihydrochloride Tablets, 0.5 mg per blister card) recalled	American Health Packaging	Processing Deviation	Nationwide
3 Jul 2019Drug	CLASS II	Pramipexole Dihydrochloride Tablets, 1.0 mg per blister card) recalled	American Health Packaging	Processing Deviation	Nationwide
3 Jul 2019Drug	CLASS II	Pramipexole Dihydrochloride Tablets, 0.125 mg per blister card) recalled	American Health Packaging	Processing Deviation	Nationwide
26 Jun 2019Drug	CLASS II	Anastrozole Tablets, USP, 1mg unit dose blisters recalledAnastrozole	American Health Packaging	Processing Deviation	Nationwide
8 May 2019Drug	CLASS II	GlipiZIDE Extended-release Tablets, 2.5 mg (3 recalled	American Health Packaging	Potency & Assay	Nationwide
27 Mar 2019Drug	CLASS II	Valsartan Tablets USP 160 mg (10 x per Unit Dose Blisters recalled	American Health Packaging	Nitrosamine Impurity	Nationwide
28 Nov 2018Drug	CLASS III	Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals) recalled	American Health Packaging	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.